Kezdőlap › Prosztatarák › Oregon › Portland
Prosztatarák klinikai vizsgálatok: Portland, OR
33 Prosztatarák vizsgálat keres résztvevőket Portland és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Toborzás folyamatban2. fázis
- VA Portland Health Care System, Portland, OR, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Toborzás folyamatban1/2. fázis
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Toborzás folyamatban3. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Toborzás folyamatban2. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mérföldre
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Toborzás folyamatban2. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Toborzás folyamatban4. fázis
- Oregon Health & Science University, Portland
Precision-Based Genomics in Prostate Cancer
Toborzás folyamatbanMegfigyeléses tanulmány
- Oregon Health Sciences University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Toborzás folyamatban1. fázis
- Oregon Health And Science University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Toborzás folyamatban1. fázis
- Providence Portland Medical Center, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Toborzás folyamatban2. fázis
- VA Portland Health Care System, Portland, OR, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Toborzás folyamatban2. fázis
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Toborzás folyamatban3. fázis
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Toborzás folyamatban3. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Toborzás folyamatban
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Toborzás folyamatban2. fázis
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Toborzás folyamatban1/2. fázis
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Toborzás folyamatban3. fázis
- Research Site, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Toborzás folyamatban3. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- és további 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Toborzás folyamatban1/2. fázis
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Toborzás folyamatban3. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- és további 1
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Toborzás folyamatban1/2. fázis
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Toborzás folyamatban2. fázis
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Toborzás folyamatbanMegfigyeléses tanulmány
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Toborzás folyamatban1. fázis
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Toborzás folyamatban
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Toborzás folyamatban
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Toborzás folyamatban2. fázis
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- és további 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Toborzás folyamatbanMegfigyeléses tanulmányEgészséges önkéntesek is jelentkezhetnek
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Toborzás folyamatbanMegfigyeléses tanulmány
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
Toborzás folyamatban2. fázisEgészséges önkéntesek is jelentkezhetnek
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Toborzás folyamatban2. fázis
- VA Portland Healthcare System, Portland
Prosztatarák vizsgálatok más városokban
- New York City, NY103 tanulmány
- Houston, TX76 tanulmány
- Los Angeles, CA61 tanulmány
- Boston, MA59 tanulmány
- St. Louis, MO46 tanulmány
- Chicago, IL45 tanulmány
- San Francisco, CA45 tanulmány
- Philadelphia, PA44 tanulmány
- Baltimore, MD43 tanulmány
- Nashville, TN43 tanulmány
- Seattle, WA42 tanulmány
- Washington, DC38 tanulmány
Egyéb vizsgálatok: Portland
- Nem kis sejtes tüdőrák46 tanulmány
- Rák (minden típus)34 tanulmány
- Mellrák33 tanulmány
- Áttétes rák29 tanulmány
- Kolorektális rák28 tanulmány
- Petefészekrák27 tanulmány
- Tüdőrák26 tanulmány
- Akut mieloid leukémia25 tanulmány
- Endometriális rák24 tanulmány
- Fej- és nyaki laphámrák19 tanulmány
- Hasnyálmirigyrák19 tanulmány
- Szívelégtelenség17 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.